Sec Form 4 Filing - FAVUS ELLIOT @ ANAVEX LIFE SCIENCES CORP. - 2015-04-02

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person FAVUS ELLIOT 2. Issuer Name and Ticker or Trading Symbol ANAVEX LIFE SCIENCES CORP. [ AVXL] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 51 W 52ND STREET, 7TH FLOOR 3. Date of Earliest Transaction (MM/DD/YY) 04/02/2015 (Street) NEW YORK, NY10019-6163 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option/Right to Buy $ 0.92 04/02/2015 A 50,000 ( 1 ) 04/02/2015( 1 ) ( 4 ) Common Stock 50,000 ( 1 ) $ 0 87,500 ( 3 ) D Stock Option/Right to Buy $ 1.68 12/31/2015 A 4,500 ( 2 ) 12/31/2015( 2 ) ( 4 ) Common Stock 4,500 ( 2 ) $ 0 92,000 ( 3 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other FAVUS ELLIOT 51 W 52ND STREET 7TH FLOOR NEW YORK, NY10019-6163 X Signatures /s/Elliot Favus, M.D 02/18/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Reporting person was granted options to purchase the equivalent of 50,000 shares of Common Stock. The options vest in three equal installments on April 2, 2015, April 2, 2016 and April 2, 2017. 16,667 of these options have vested as of the date of this filing. Initially, 200,000 options were granted which were adjusted to 50,000 options to reflect a 1-for-4 reverse stock split effected on October 6, 2015. ( 2 )Pursuant to the Company's current obligation to grant to Dr. Favus options to purchase 1,500 shares at the end of each fiscal quarter as compensation for service on Board Committees, an aggregate of 4,500 options were granted to Dr. Favus for quarters ended June 30, 2015, September 30, 2015 and December 31, 2015, which options vested on December 31, 2015. ( 3 )Includes options to purchase 37,500 shares of common stock at an exercise price of $1.20, to vest annually over a three year period commencing May 7, 2015, 12,500 of which have vested. Initially, 150,000 options were granted which were adjusted to 37,500 options to reflect a 1-for-4 reverse stock split effected on October 6, 2015. ( 4 )N/A

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.